These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2432136)

  • 1. Hyperthermia, chemotherapeutic agents and oncogenic transformation.
    Hei TK; Hall EJ; Kushner S; Osmak RS
    Int J Hyperthermia; 1986; 2(3):311-20. PubMed ID: 2432136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of hyperthermia and chemotherapy agents; cell lethality and oncogenic potential.
    Miller RC; Richards M; Baird C; Martin S; Hall EJ
    Int J Hyperthermia; 1994; 10(1):89-99. PubMed ID: 7511674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oncogenic potential of a combination of hyperthermia and chemotherapy agents.
    Komatsu K; Miller RC; Hall EJ
    Br J Cancer; 1988 Jan; 57(1):59-63. PubMed ID: 3126790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of cisplatin plus etoposide with radiation +/- hyperthermia.
    Pfeffer MR; Teicher BA; Holden SA; al-Achi A; Herman TS
    Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1439-47. PubMed ID: 2262368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of heat with X-rays and cis-platinum; cell lethality and oncogenic transformation.
    Miller RC; Roizin-Towle L; Komatsu K; Richards M; Hall EJ
    Int J Hyperthermia; 1989; 5(6):697-705. PubMed ID: 2592783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses of RIF tumors to heat and drugs: dependence on tumor size.
    Li DJ; Hahn GM
    Cancer Treat Rep; 1984 Sep; 68(9):1149-51. PubMed ID: 6206943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergism between alkylating agent and cis-platin with moderate local hyperthermia: the effect of multidrug chemotherapy in an animal system.
    Matsushita S; Reynolds R; Urano M
    Int J Hyperthermia; 1993; 9(2):285-96. PubMed ID: 8468510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermochemotherapy with cis-platinum, CCNU, BCNU, chlorambucil and melphalan on murine marrow and two tumours: therapeutic gain for melphalan only.
    Honess DJ; Bleehen NM
    Br J Radiol; 1985 Jan; 58(685):63-72. PubMed ID: 4063642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues with cis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia or radiation.
    Teicher BA; Pfeffer MR; Alvarez Sotomayor E; Herman TS
    Int J Hyperthermia; 1991; 7(5):773-84. PubMed ID: 1834752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimodality therapy (drug/hyperthermia/radiation) with BCNU or mitomycin C.
    Herman TS; Teicher BA; Holden SA
    Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):375-82. PubMed ID: 2105922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic potential of bifunctional bioreductive drugs.
    Hei TK; Liu SX; Hall EJ
    Br J Cancer Suppl; 1996 Jul; 27():S57-60. PubMed ID: 8763847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical hyperthermia and chemotherapy.
    Storm FK
    Radiol Clin North Am; 1989 May; 27(3):621-7. PubMed ID: 2648463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
    Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
    Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy and total body hyperthermia].
    Yamanaka N; Kato N
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2100-5. PubMed ID: 2415067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combined treatment with 40 degrees C hyperthermia and bleomycin on the accumulation of heat shock protein in murine L cells.
    Jin ZH; Shioura H; Kano E; Hayashi S; Hatashita M; Matsumoto H; Ohtsubo T
    Int J Oncol; 2002 Jan; 20(1):137-42. PubMed ID: 11743654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of alkylating agent cytotoxicity by cisplatin.
    Horsman MR; Hirst DG; Brown DM; Brown JM
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1669-73. PubMed ID: 6541216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined modality therapy with bleomycin, hyperthermia, and radiation.
    Teicher BA; Herman TS; Holden SA
    Cancer Res; 1988 Nov; 48(22):6291-7. PubMed ID: 2460220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination and individual antitumor effects of hyperthermia, cisplatin, and selected dithiocarbamates.
    Walker EM; Schaefer RF; Henle KJ; Schmidt BJ; Gale GR; Cannon DJ; Jones MM; Moss AJ
    Ann Clin Lab Sci; 1989; 19(4):242-54. PubMed ID: 2757352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of combined cis-platinum and cyclophosphamide by local hyperthermia in mice bearing the Lewis lung carcinoma.
    Hazan G; Lurie H; Yerushalmi A
    Oncology; 1984; 41(1):68-9. PubMed ID: 6538329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.